Abstract
Background
This study evaluated the prevalence and symptoms of sexual and urinary disorders in patients with multiple sclerosis. Methods: MEDLINE, ISI Web of Science, PubMed, EMBASE, Scopus, ProQuest, and Science Direct were searched to find the articles published during 2000–2018.The quality of the selected studies was determined based on STROBE checklist. Moreover, I2 and Cochrane Q-test were used to determine heterogeneity. Also, fixed effects and/or random effects models were applied to estimate pooled prevalence. The effects of variables were then assessed through subgroup analysis and meta-regression. Results: The pooled prevalence of sexual and urinary disorders was 52.2% (95% CI [44.2–60.1]) and 49.5% (95% CI [25.3–73.8]), respectively. Notably, the pooled prevalence of sexual disorders was found to be 47.1% (95% CI [36.0–58.3]) in women and 48.4% (95% CI [37.8–59.0]) in men. Conclusion: Supportive measures, counseling, and education, should be incorporated into the routine healthcare programs for patients with MS.
Disclosure statement
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
Correction Statement
This article has been republished with minor changes. These changes do not impact the academic content of the article.